Quality-of-Life Outcomes Among Patients Achieving High-Threshold Facial or Total Body Repigmentation With Ruxolitinib Cream in Nonsegmental Vitiligo. J of Skin 2026, 10 (2), s753. https://doi.org/10.25251/r559dc08.